Illumina is off to a racing start in 2016, and the pace isn't showing any signs of slowing. The company is snatching up Conexio Genomics to get its hands on Conexio's transplant genotyping products, a couple of weeks after it unveiled its liquid biopsy spinoff and expanded genomics offerings.
Toshiba appears on track to earn more than $3 billion from the sale of its medical device unit to help it recover from an accounting scandal, as the list of companies bidding on Toshiba Medical Systems grows, just prior to the Friday deadline.
This year's med tech IPOs have gotten off to a rather underwhelming start. But given the rocky broader stock market and the dearth of recent IPOs in the sector, that's not too surprising. The inaugural med tech IPO filing of 2016 is for at-home compression wrap company Tactile Systems Technology to raise up to $86 million.
Surging Democratic presidential candidate Sen. Bernie Sanders of Vermont said he will try to block the nomination of President Obama's nominee to be the next FDA commissioner, current deputy commissioner for medical products and tobacco, Dr. Robert Califf.
Interoperability is an increasingly important component of med tech, due to the need for communication and data exchange within a networked system of other devices, electronic health records and clinicians. Poor interoperability is blamed for problems like "alarm fatigue" whereby poorly networked devices produce an excessive number of loud warnings out of an abundance of caution, leading to the risk that a necessary alarm will be ignored.
After disclosing a major restructuring of its medical device business last week, Johnson & Johnson tried to refocus on the future of that group on its annual earnings call. It emphasized doing more deals to acquire platforms for growth, as well as funneling more resources to high revenue growth device groups.
The U.K.'s Inivata raked in £31.5 million ($45 million) in a Series A round to bolster development for its liquid biopsy test for lung cancer, funds that will help the company set itself apart in competitive field and build on recent momentum.
Japan's Fujifilm announced 510(k) and CE mark approval of its SonoSite Edge II portable ultrasound system.
Precision medicine is growing by leaps and bounds, and Oracle is wise to the trend. The company is unveiling a new business aimed at facilitating genetic testing to uncover better treatments for patients.
U.K. company Zilico has published a case study of its diagnostic for high-grade cervical intraepithelial neoplasia, dubbed ZedScan.
Intuitive Surgical is the only shop in town for minimally invasive robotic surgery, as opposed to open surgery and less invasive laparoscopic (or "keyhole") surgery, but competitors big and small are gearing up to mount a challenge.
Kyoto University and Panasonic have revealed a novel vital-sign-sensing technology that's based on radar. This enables the system to remotely detect heart rate and heartbeat interval without any sensors being placed on the patient's body. The accuracy of the system is on par with electrocardiographs.
Johnson & Johnson's DePuy unit has faced plenty of pushback the past few years over its all-metal hip implants, with patients suing the company for alleged design defects causing pain and injury. Now the company is in the hot seat again, and this time, it's for manufacturing problems in the U.K. linked to the devices.
Munich-based radiotherapy company, Brainlab, has invested a $7.5 million Series C financing into Mountain View, CA-based startup Jan Medical. The cash infusion is earmarked for the completion of ongoing clinical trials and submission of its neurological diagnostic software, Nautilus BrainPulse, to regulators.
Things keep going from bad to worse for Theranos, and the latest chapter in the company's ongoing saga over its proprietary testing technology isn't looking any rosier. The Centers for Medicare and Medicaid Services (CMS) has uncovered serious problems at Theranos' Northern California lab, adding to the company's recent string of regulatory woes.
Bad things happen to private equity-owned companies that do not achieve an "exit" for their investors. For instance, Luxembourg's wound care player ConvaTec will begin closing its Greensboro, NC, manufacturing facility in July, resulting in 250 layoffs, North Carolina's job loss database shows.
Los Angeles' Cedars-Sinai Medical Center is seeking to assess the mobility of cancer patients during chemotherapy using the Fitbit Charge HR.
Wall Street may be waiting for Royal Philips to get rid of its lighting businesses to give the conglomerate any credit for its moves to create a business focused solely on healthcare and consumer technologies. If so, they may have to wait a little while longer. A lighting deal has fallen through under U.S. regulatory scrutiny, but Philips said that this won't impact plans for its remaining lighting business.
The U.S. Department of Defense (DOD) has set its sights on developing traumatic brain injury (TBI) technology for a while now, doling out $15 million in contracts in 2014 to a company creating a device for the condition. In its latest move, the DOD is enlisting the University of Michigan for a new project aimed at addressing TBI through med tech.
The United Kingdom's National Health Service sees med tech as crucial to addressing healthcare improvements. It's launched a series of 7 trials with several major technology partners designed to test several means of integrating med tech specifically into at-home care for elderly and chronic disease patients.